House Bill No. [insert bill number] aims to establish the "Right to Refuse Emergency Use Authorization Drugs Act" in Louisiana, which allows individuals to refuse medical treatments that have only received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA). The bill enacts new provisions under R.S. 40:1162.1 through 1162.3, which require healthcare providers to inform patients of their right to refuse such treatments. This includes providing written and verbal notice about the drug's EUA status, the risks and benefits associated with it, and the alternatives available. Healthcare providers must also document the patient's decision to refuse treatment in their medical records.

Additionally, the bill emphasizes that individuals cannot face discrimination or negative consequences for refusing a covered drug or vaccine, such as denial of treatment or loss of employment. It mandates that healthcare providers obtain acknowledgment from patients regarding the notice provided, which does not equate to consent for treatment. Failure to comply with these requirements may result in disciplinary actions against the healthcare provider, including potential revocation or suspension of their license. Overall, the bill seeks to enhance patient autonomy and informed consent in the context of emergency use medical products.